Reported Sep 25, 2019 · Terminated

fexofenadine hydrochloride tablets USP, 180 mg, 150-count bottle, Member's Mark, Distributed by: Sam's West, Inc.,…

Aurolife Pharma, LLC

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Aurolife Pharma, LLC · 2400 US Highway 130 · Dayton, NJ · 08810-1519

Is this the product you have?

  • fexofenadine hydrochloride tablets USP, 180 mg, 150-count bottle, Member's Mark
  • Distributed bySam's West, Inc., Bentonville, AR 22716, NDC 68196-976-91, UPC 0 78742 23550 9
Lot codes and dates
    • Lot #'s: 067180009A
    • Exp 03/21
    • 067180013A
    • 067180014A
    • 067180015A
    • Exp 04/21
    • 067180018A
    • Exp 05/21
    • 067180020A
    • Exp 06/21
    • 067180021A1
    • 067180022A1
    • Exp 07/21
    • 06718028A1
    • 06718028B1
    • Exp 09/21
    • 06719001A3
    • Exp 01/22
Amount recalled
71,748 bottles

This recall covers 11 products

The agency filed one notice per product. You are reading one of them; the other 10 are below.

Where it was sold

  • Nationwide

Why it was recalled

Failed Impurities/Degradation Specifications

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Aurolife Pharma, LLC recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Aug 16, 2022 · Data as of Sep 19, 8:37 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.